FDA reviews new interpretation of study on Avandia risks
The FDA is set to weigh in on lifting safety restrictions on the diabetes drug Avandia.
June 6, 2013
Menu
The FDA is set to weigh in on lifting safety restrictions on the diabetes drug Avandia.
The FDA is set to weigh in on lifting safety restrictions on the diabetes drug Avandia.
